Article Details

Mozart Therapeutics doses first patients in trial of MTX-101 for autoimmune diseases

Retrieved on: 2024-06-18 15:36:49

Tags for this article:

Click the tags to see associated articles and topics

Mozart Therapeutics doses first patients in trial of MTX-101 for autoimmune diseases. View article details on hiswai:

Excerpt

The gold standard of business intelligence. Find out more. The subsequent Phase Ib portion will assess the drug's safety, PK, PD and disease ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up